Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Bozorgmehr F, et al. Among authors: chung i. BMC Cancer. 2020 Aug 26;20(1):806. doi: 10.1186/s12885-020-07264-8. BMC Cancer. 2020. PMID: 32842974 Free PMC article.
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer.
Bozorgmehr F, Kazdal D, Chung I, Kirchner M, Magios N, Kriegsmann M, Allgäuer M, Klotz LV, Muley T, El Shafie RA, Fischer JR, Faehling M, Stenzinger A, Thomas M, Christopoulos P. Bozorgmehr F, et al. Among authors: chung i. Front Oncol. 2021 Apr 9;11:640048. doi: 10.3389/fonc.2021.640048. eCollection 2021. Front Oncol. 2021. PMID: 33898315 Free PMC article.
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.
Christopoulos P, Bozorgmehr F, Brückner L, Chung I, Krisam J, Schneider MA, Stenzinger A, Eickhoff R, Mueller DW, Thomas M. Christopoulos P, et al. Among authors: chung i. BMC Cancer. 2021 Jun 28;21(1):743. doi: 10.1186/s12885-021-08460-w. BMC Cancer. 2021. PMID: 34182952 Free PMC article. Clinical Trial.
Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease - a randomized, open-label, multicenter phase II trial.
Bozorgmehr F, Christopoulos P, Chung I, Cvetkovic J, Feißt M, Krisam J, Schneider MA, Heußel CP, Kreuter M, Müller DW, Thomas M, Rieken S. Bozorgmehr F, et al. Among authors: chung i. BMC Cancer. 2022 Sep 24;22(1):1011. doi: 10.1186/s12885-022-10074-9. BMC Cancer. 2022. PMID: 36153496 Free PMC article.
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
Bozorgmehr F, Chung I, Christopoulos P, Krisam J, Schneider MA, Brückner L, Mueller DW, Thomas M, Rieken S. Bozorgmehr F, et al. Among authors: chung i. BMC Cancer. 2023 Aug 10;23(1):740. doi: 10.1186/s12885-023-11270-x. BMC Cancer. 2023. PMID: 37563548 Free PMC article. No abstract available.
A comparative survey between cascade correlation neural network (CCNN) and feedforward neural network (FFNN) machine learning models for forecasting suspended sediment concentration.
Joshi B, Singh VK, Vishwakarma DK, Ghorbani MA, Kim S, Gupta S, Chandola VK, Rajput J, Chung IM, Yadav KK, Mirzania E, Al-Ansari N, Mattar MA. Joshi B, et al. Among authors: chung im. Sci Rep. 2024 May 9;14(1):10638. doi: 10.1038/s41598-024-61339-1. Sci Rep. 2024. PMID: 38724562 Free PMC article.
1,980 results